Continuous Glucose Monitoring Market Research Explores Growth Within A $18.85 Billion Opportunity

The continuous glucose monitoring market is rapidly evolving as advancements in technology and healthcare demand more efficient diabetes management tools. With a rising global diabetic population and innovations in sensor technologies, this market is set to experience significant growth and transformation over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation details shaping the future of continuous glucose monitoring.

Forecasted Expansion of the Continuous Glucose Monitoring Market Size by 2030
The continuous glucose monitoring market is projected to reach $18.86 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 14.8%. This expansion is driven by technological progress in implantable and wearable sensors, the integration of these devices with mobile health and telemedicine platforms, and the increasing global incidence of diabetes. Additionally, the rise of non-invasive glucose monitoring solutions and the growth of home healthcare and remote patient monitoring services contribute to the market's promising outlook. Key trends shaping the market include the widespread adoption of CGM devices among diabetic patients, breakthroughs in minimally invasive and implantable sensors, incorporation of real-time data analytics and alert systems, growth of telehealth and home-based monitoring options, and a rising focus on glucose monitoring for both pediatric and geriatric populations.

Download a free sample of the continuous glucose monitoring market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24512&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Leading the Continuous Glucose Monitoring Market
Several prominent firms currently dominate the continuous glucose monitoring industry, including Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, and POCTech Co Ltd.
In a notable development in September 2023, Abbott Laboratories acquired Bigfoot Biomedical, a US-based medical technology company specializing in diabetes management systems that combine continuous glucose monitoring technology. This acquisition aims to enhance Abbott's Freestyle Libre CGM technology and expand its portfolio by developing advanced connected diabetes care solutions that offer more personalized and precise management.

Emerging Innovations Shaping the Continuous Glucose Monitoring Market
Industry leaders are placing a strong emphasis on developing innovative sensor-based glucose monitors to improve accuracy, real-time monitoring, and ease of use for patients. These devices use small sensors inserted under the skin to continuously track blood sugar levels without constant fingersticks. For example, in August 2024, DexCom, Inc. launched Stelo, the first over-the-counter continuous glucose monitor designed for adults who do not require insulin. Stelo offers continuous, real-time glucose readings through a discreet sensor worn on the back of the upper arm, with data transmitted directly to a smartphone app. No prescription or fingerstick calibration is necessary, making this an accessible option for individuals with Type 2 diabetes not on insulin, prediabetes, or anyone interested in glucose health monitoring. The sensor lasts up to 15 days, integrates with health applications, and provides personalized insights into how lifestyle factors impact glucose levels, enabling users to make smarter health decisions.

View the full continuous glucose monitoring market report:
https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

How the Continuous Glucose Monitoring Market is Categorized
The continuous glucose monitoring market is organized into several key segments:
1) Component types, including Transmitters, Sensors, and Receivers.
2) Age groups, divided between Adults and Children.
3) End-use settings such as Hospitals, Home Care Settings, Diagnostic Centers and Clinics, and other relevant uses.

Further subcategories exist within these segments:
- Transmitters are classified as Reusable, Disposable, or Rechargeable.
- Sensors include Implantable, Transcutaneous, Disposable, and Real-Time types.
- Receivers are distinguished into Standalone, Integrated, and Wearable Display Devices.

This segmentation provides a comprehensive view of the various components and applications within the continuous glucose monitoring market, reflecting its diverse and expanding nature.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.